HBV-Derived Synthetic Long Peptide Can Boost CD4(+) and CD8(+) T-Cell Responses in Chronic HBV Patients Ex Vivo

Author(s):
Dou, Y.Y.; Montfoort, N. van; Bosch, A. van den; Man, R.A. de; Zom, G.G.; Krebber, W.J.; Melief, C.J.M.; Buschow, S.I.; Woltman, A.M.
Published
2018
Publication type
Article / Letter to editor
cross-presentationsynthetic long peptide vaccinehuman dendritic cellHBVT cell
Date issued
2018-03-01
Language
English
Is part of
Journal of Infectious Diseases (2018), Vol. 217, no. 5, p. 827-839
hdl
1887/96577
doi
10.1093/infdis/jix614